Overview

City of Hope is a world leader in the research and treatment of cancer, diabetes, and other serious diseases. It has been ranked as one of the nation’s Best Hospitals for cancer treatment by U.S. News & World Report for over a decade. In 2018, the Simms/Mann Family Foundation partnered with City of Hope to establish the Simms/Mann Family Foundation Chair in Systems Biology. Jianjun Chen, PhD is the inaugural chairholder. Dr. Chen is a leader in using systems biology to address disparities in therapeutic options for acute leukemia.

 

cityofhope.org/jianjun-chencityofhope.org/research

Jianjun Chen, PhD and his team at City of Hope’s Chen Lab.

Desired Impact

People around the world fighting cancer find hope in the promise of experimental new therapies that may lead to a cure for themselves and future generations. In recent years, Dr. Chen and his colleagues have been focusing on research associated with RNA/DNA epigenetics.

The Simms/Mann Family Foundation provides Dr. Chen with the tools to pursue his transformative research. As he translates laboratory discoveries into the development of effective novel therapeutic strategies to treat cancers—especially acute leukemia— Dr. Chen works to redefine the way the world understands and treats cancer and lays the foundation for the brilliant researchers who will follow in his footsteps.

Endowed Chair 

Jianjun Chen, PhD

Simms/Mann Endowed Chair; professor and chair of the Department of Systems Biology

Jianjun Chen, PhD joined City of Hope in 2017. His goal is to translate laboratory discoveries into the development of effective novel therapeutic strategies to treat cancers, especially acute leukemia.

View Bio

With the support of Simms/Mann, City of Hope will be able to hasten innovative research that puts cures for patients into doctors’ hands more quickly.”

Robert Stone, President & CEO of City of Hope